CLXT - Calyxt, Inc.

Calyxt, Inc.

2800 Mount Ridge Road
Roseville, MN 55113-1127
United States
651 683 2807
https://calyxt.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 48

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Michael Allen Carr	Pres, CEO & Director	543.56k	N/A	1970
Mr. William F. Koschak	Chief Financial Officer	356.74k	N/A	1969
Dr. Travis J. Frey Ph.D.	Chief Technology Officer	314.76k	N/A	1979
Ms. Debra H. Frimerman	Gen. Counsel & Corp. Sec.	334.08k	N/A	1980
Dr. Daniel F. Voytas Ph.D.	Founder, Chief Science Officer & Chair of Scientific Advisory Board	N/A	N/A	1963
Dr. Stephen M. Bravo	Chief Medical Officer	N/A	N/A	N/A
Mr. Gerry Nuovo	Sr. VP of Bus. Devel.	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.

Corporate governance

Calyxt, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.